Posted by Michael Wonder on 28 Jun 2016
TGA publishes AusPAR for Proshaeos (alprostadil)
28 June 2016 - The TGA has published an AusPAR for Montrose Pharma's Proshaeos (alprostadil).
This AusPAR describes the application by Commercial Eyes on behalf of Montrose Pharma to register a new dosage form of alprostadil for the treatment of erectile dysfunction. The submission was withdrawn.
